Background Olaparib has shown significant clinical benefit as maintenance therapy in
women with newly diagnosed advanced ovarian cancer with a BRCA mutation. The effect of …

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian
Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39) …

Background Platinum-based chemotherapy is the foundation of treatment for platinum-
sensitive recurrent ovarian cancer, but has substantial toxicity. Bevacizumab and …

OBJECTIVE: To examine the association between premenopausal use of the levonorgestrel-
releasing intrauterine system and cancer incidence in Finland with a special focus on …

Background Previous studies comparing robotic-assisted laparoscopic surgery to traditional
laparoscopic or open surgery in gynecologic oncology have been retrospective. To our …

The purpose of the study was to compare postoperative vaginal irradiation with surgery
alone in low-risk International Federation of Gynecology and Obstetrics (FIGO) stage IA-IB …

Background Cesarean scar defect (isthmocele) is a known complication after cesarean
delivery. It has become more common due to a rising cesarean delivery rate. Isthmocele has …

OBJECTIVE: Our purpose was to establish whether platinum-based chemotherapy
combined with standard surgery and radiotherapy will improve overall and disease-free …

Background Radical hysterectomy with pelvic lymphadenectomy represents the standard
treatment for early-stage cervical cancer. Results from a recent randomized controlled trial …

Background. Prolonged steroid hormone therapy increases the risk of breast cancer,
especially the risk of lobular cancer, but the effect of the levonorgestrel-releasing intrauterine …